Clinical and dosimetric aspects in concurrent radiotherapy with CDK4/6 inhibitors in breast cancer

被引：0
|
作者：
Rebegea, Laura Florentina [1 ,2 ,3 ]
Ilie, Ana Maria [1 ]
Anghel, Rodica [4 ]
Lungu, Mihaela [2 ,5 ]
Dumitru, Mihaela Emilia [1 ]
机构：
[1] Sfantul Apostol Andrei Emergency Clin Hosp, Dept Radiotherapy, Galati 800578, Romania
[2] Univ Galatzi, Fac Med & Pharm, Dept Clin Med, Galati, Romania
[3] Univ Galatzi, Res Ctr Field Med & Pharmaceut Sci, ReFORM UDJ, Galati, Romania
[4] Carol Davila Univ Med & Pharm, Dept Clin Med, Bucharest, Romania
[5] Sfantul Apostol Andrei Emergency Clin Hosp, Dept Neurol, Galati 800578, Romania
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
radiotherapy; CDK4/6i; toxicities;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2226
引用
收藏
页码：S632 / S633
页数：3
相关论文
共 50 条
  • [41] Targeting CDK4/6 in breast cancer
    Shanabag, Anusha
    Armand, Jessica
    Son, Eugene
    Yang, Hee Won
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2025, 57 (02): : 312 - 322
  • [42] CDK4/6 inhibitors
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 30 - 31
  • [43] Outcomes and toxicity of concurrent CDK4/6 inhibitor and locoregional radiotherapy for patients with de novo metastatic breast cancer
    Beddok, Arnaud
    Mouren, Victoire
    Cottu, Paul
    Laki, Fatima
    Fourquet, Alain
    Kirova, Youlia
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (07) : 1386 - 1396
  • [44] SBRT with CDK4/6 inhibitors for oligorecurrent/oligoprogressive breast cancer patients
    Ippolito, E.
    Onorati, E.
    Greco, C.
    Fiore, M.
    Silipigni, S.
    Matteucci, P.
    Cerasani, L.
    Carrafiello, S.
    Palumbo, V.
    Ramella, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1298 - S1298
  • [45] CDK4/6 inhibitors in HR-positive breast cancer immunotherapy
    Shen, Mimi
    Ma, Zhiyuan
    Zhu, Jiaxing
    Wen, Guorong
    Jin, Hai
    An, Jiaxing
    Tuo, Biguang
    Liu, Xuemei
    Li, Taolang
    BIOORGANIC CHEMISTRY, 2025, 154
  • [46] The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer
    Gomes, Ines
    Abreu, Catarina
    Costa, Luis
    Casimiro, Sandra
    CANCERS, 2023, 15 (19)
  • [47] Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast Cancer
    Echavarria, Isabel
    Jerez, Yolanda
    Martin, Miguel
    Lopez-Tarruella, Sara
    BREAST CARE, 2017, 12 (05) : 296 - 302
  • [48] Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancer
    Loibl, Sibylle
    Furlanetto, Jenny
    BREAST, 2022, 62 : S70 - S79
  • [49] CDK4/6 inhibitors in HER2-positive breast cancer
    Corona, Silvia Paola
    Ravelli, Andrea
    Cretella, Daniele
    Cappelletti, Maria Rosa
    Zanotti, Laura
    Dester, Martina
    Gobbi, Angela
    Petronini, Pier Giorgio
    Generali, Daniele
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 112 : 208 - 214
  • [50] Recent advances of highly selective CDK4/6 inhibitors in breast cancer
    Hanxiao Xu
    Shengnan Yu
    Qian Liu
    Xun Yuan
    Sridhar Mani
    Richard G. Pestell
    Kongming Wu
    Journal of Hematology & Oncology, 10
12345